Navigation Links
Brachytherapy For Breast Cancer Can Be Risky

A new study published in the June 2006 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society //for Therapeutic Radiology and Oncology, says that doctors in New England have found that patients receiving partial radiation for the breast in order to combat breast cancer have the risk of developing a seroma.

A seroma is retention of fluid in the breast, which can complicate matters since it requires aspiration. The study followed 38 women who had the procedure after undergoing lumpectomy surgery to remove the cancer. After the surgery, a balloon brachytherapy method is used to place a balloon in the space occupied by the tumor.

Radiation Oncologists then deliver high doses of radiation locally in order to kill off any remaining cancer cells. In the current study 76.3 percent of them developed seroma in their breast and 68.4 percent of the patients had it for over 6 months.

'Seroma is not infrequent after surgery, but it typically resolves itself within a few weeks. However, with these patients, the seroma didn’t resolve,' said Suzanne B. Evans, M.D., M.P.H., lead author of the study and a radiation oncology resident at Tufts-New England Medical Center. 'We look forward to other studies in which the device is placed post-operatively to determine whether this lowers the rate of seroma formation.'


'"/>




Page: 1

Related medicine news :

1. Brachytherapy for breast cancer
2. Brachytherapy Shows Promise for Cancer Treatment
3. Prostate Brachytherapy Causes Fewer Side Effects Than Surgery
4. Consensus on "Combination Therapy" for Breast Cancer
5. Breast cancer treatment to be determined by gene test
6. Breast Feeding prevents obesity later on in life
7. Breast milk is essential
8. Breast Cancer Surgery Causes Psychological problems
9. Breast cancer evidence
10. Letrozole Beats Tamoxifen in Breast Cancer Therapy
11. Breast screening among diabetic women
Post Your Comments:
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 1Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 2Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 3Par Pharmaceutical Announces Results of Its Modified Dutch Auction Tender Offer 62113 1Par Pharmaceutical Announces Results of Its Modified Dutch Auction Tender Offer 62113 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 1Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 9